Trial of Oral Melatonin in Elevated Blood Pressure
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Since, lowering blood pressure (BP) in elevated blood pressure individuals represents an
excellent opportunity to for primary prevention of hypertension (HTN). Therefore, it is
planned to use a safe treatment option - oral melatonin supplementation - associated with
lifestyle interventions according to the American college of cardiology/American heart
association (ACC/AHA) 2013 guideline in elevated blood pressure individuals to mitigate
systolic and diastolic BP and ultimately, to prevent the development of HTN.
Hypothesis:
Melatonin therapy can lower the systolic and diastolic BP of elevated blood pressure
individuals Melatonin can attenuate levels of circulatory biomarkers of Hs- CRP, Cholesterol,
LDL-c and triglyceride